Biofrontera (BFRI) Shares Outstanding (2020 - 2026)
Biofrontera (BFRI) posted quarterly Shares Outstanding (Entity) of $11.6 million for Q4 2025, up 111.16% year-over-year from $5.5 million in Q4 2024, and little changed quarter-over-quarter from $11.6 million in Q3 2025.
Biofrontera (BFRI) Shares Outstanding (2020 - 2026) Analysis & Trends
Biofrontera's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $11.6 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 111.16% year-over-year to $11.6 million; the TTM figure through Dec 2025 stood at $11.6 million (up 111.16% YoY), while the FY2025 annual figure was $11.6 million, up 111.16% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $11.6 million, roughly flat from $11.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $440.4 million in Q4 2021, with the low at $400000.0 in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $1.4 million (2023), against an average of $25.7 million.
- The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) soared 799900.0% in 2021, then plunged 99.76% in 2022.
- Biofrontera's Shares Outstanding (Entity) stood at $440.4 million in 2021, then slumped by 99.76% to $1.1 million in 2022, then soared by 43.58% to $1.5 million in 2023, then surged by 263.48% to $5.5 million in 2024, then soared by 111.16% to $11.6 million in 2025.
- Business Quant data shows BFRI's Shares Outstanding (Entity) at $11.6 million in Q4 2025, $11.6 million in Q3 2025, and $10.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 12.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.92 Mn |
| Dec 31, 2025 | 10.17 Mn |
| Sep 30, 2025 | 10.78 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 5.52 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 941,175.00 |
| Mar 31, 2022 | 855,237.00 |
| Dec 31, 2021 | 440.41 Mn |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |